UvA-DARE ( Digital Academic Repository ) A method to assess the clinical significance of unclassified variants in the BRCA 1 and BRCA 2 genes based on cancer family history

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.

  2008cited by this paper
• Functional assays for classification of BRCA2 variants of uncertain significance.

  2008influential reference
• Genetic evidence and integration of various data sources for classifying uncertain variants into a single model

  2008cited by this paper
• A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.

  2007cited by this paper
• Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?

  2007influential reference
• Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.

  2006cited by this paper
• Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

  2006influential reference
• Evaluation of models to predict BRCA germline mutations

  2006cited by this paper
• Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.

  2005cited by this paper
• Insights into the Molecular Basis of Human Hereditary Breast Cancer from Studies of the BRCA1 BRCT Domain

  2005influential reference
• Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.

  2005influential reference
• Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation.

  2005cited by this paper
• Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations

  2004cited by this paper
• Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer

  2004influential reference
• Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

  2004cited by this paper
• Understanding missense mutations in the BRCA1 gene: An evolutionary approach

  2003cited by this paper
• Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer

  2002cited by this paper
• Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

  2002cited by this paper
• Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography.

  2002cited by this paper
• BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

  2002cited by this paper
• Characterization of Common BRCA1 and BRCA2 Variants

  2002cited by this paper
• Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

  2001influential reference
• BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

  2001influential reference
• Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

  1998cited by this paper
• Gentleman R: R: A language for data analysis and graphics

  1996cited by this paper
• Amino Acid Difference Formula to Help Explain Protein Evolution

  1974cited by this paper
• Information Theory and an Extension of the Maximum Likelihood Principle

  1973cited by this paper

• The Pathogenic R3052W BRCA2 Variant Disrupts Homology-Directed Repair by Failing to Localize to the Nucleus

  2022cites this paper
• BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning.

  2022cites this paper
• Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules

  2021cites this paper
• A Danish national effort of BRCA1/2 variant classification

  2018cites this paper
• The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

  2017cites this paper
• Assessing biases of information contained in pedigrees for the classification of BRCA-genetic variants: a study arising from the ENIGMA analytical working group

  2016cites this paper
• Classification and Clinical Management of Variants of Uncertain Significance in High Penetrance Cancer Predisposition Genes

  2016cites this paper
• Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients

  2016cites this paper
• DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer

  2015cites this paper
• Functional Classification of BRCA2 DNA Variants by Splicing Assays in a Large Minigene with 9 Exons

  2015cites this paper
• Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.

  2015cites this paper
• Management of Hereditary Ovarian–Breast Cancer

  2014cites this paper
• Functional Assays for Analysis of Variants of Uncertain Significance in BRCA2

  2014cites this paper
• The BRCA1 Variant p.Ser36Tyr Abrogates BRCA1 Protein Function and Potentially Confers a Moderate Risk of Breast Cancer

  2014cites this paper
• Genetic testing and familial implications in breast-ovarian cancer families.

  2014cites this paper
• Assessing Genetic Variants of Uncertain Significance: The Example of Breast Cancer

  2013cites this paper
• Editorial: BRCA1 and BRCA2 gene mutations screening in sporadic breast cancer patients in Kazakhstan

  2013cites this paper
• A review of a multifactorial probability‐based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)

  2012cites this paper
• Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes

  2012cites this paper
• Variants of Uncertain Significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling

  2012cites this paper
• BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

  2012cites this paper
• ENIGMA—Evidence‐based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes

  2012cites this paper
• Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.

  2012cites this paper
• Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

  2011cites this paper
• Variants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.

  2011cites this paper
• Erratum: Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

  2011cites this paper
• Model of care for women at increased risk of breast and ovarian cancer

  2011cites this paper
• Evaluation of the disease liability of CFTR variants.

  2011cites this paper
• Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal

  2010cites this paper
• A missense variant within BRCA1 exon 23 causing exon skipping.

  2010cites this paper
• Characterization of BRCA1 ring finger variants of uncertain significance

  2010cites this paper
• The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers

  2010cites this paper
• Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity

  2010cites this paper
• Clinical relevance of rare germline sequence variants in cancer genes: evolution and application of classification models.

  2010cites this paper
• Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant

  2009cites this paper
• Exploring the Pathogenic and Therapeutic Implications of Aberrant Splicing in Breast Cancer

  2009cites this paper